Open Menu Close Menu

To encourage meritorious scientific and clinical studies designed to improve the diagnosis or therapy of Homocystinuria due to Cystathionine Beta-Synthase Deficiency. Grants will be awarded to academic researchers to initiate small scientific research studies or clinical trials, the results of which could be used to obtain funding from NIH, FDA or other funding agencies, or to attract a corporate sponsor. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary states of clinical investigation. Protocols that will focus on cause, early detection, diagnosis, or treatment (pharmacological, devices, surgery, or dietary) will be given priority.